feed,title,long_url,short_url
MedRxiv,"Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial",https://medrxiv.org/cgi/content/short/2021.06.30.21259439v1?rss=1,https://j.mp/3jCBUvD
